Yimei concept stocks weakened in early trading, and Huaxi biology fell more than 10%
Medical beauty concept stocks weakened in early trading. As of press time, Huaxi biology fell by more than 10%, Aier ophthalmology fell by more than 8%, and Haohai Shengke, aimeike and Aoyuan Meigu followed suit.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
Synthetic Biology: Who Will Emerge as the Winner?
The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.
Jun 27, 2022 12:38 PM
Briefing Jun 28, 2022 12:09 PM
· Real Estate
The second batch of homesteads sold intensively in Shanghai this year began to trade 32 plots from July 25, reducing the quantity and improving the quality
Jan 06, 2023 08:30 AM
Nov 16, 2022 05:19 PM
Nov 08, 2022 08:32 AM
Nov 07, 2022 04:27 PM
Briefing Jun 24, 2022 07:24 AM
· Real Estate
Financial associated press commentary: don't rush to deny the "wheat house exchange"
Briefing Jun 23, 2022 02:03 PM
· Industrials
Samsung and apple smartphones began to enter Russia through parallel import channels
Technology
Xiaomi's Q3 Net Profit Surged by 182.9% YoY, while R&D Spending Rises to CNY 5 Billion
Smartphone makers' product matrix is one of the sources of competitive advantage, and applications such as the Internet of Things and smart electric vehicles will be a future trend.
Nov 21, 2023 03:51 PM
Briefing Jun 19, 2022 01:29 PM
Xiaomi 618's Omni channel payment exceeded 18.7 billion yuan
See more
Read next
Insight
In-depth
Insight
In-depth